Trending...
- Twitch Streamer Caiuwus Emerges From "Streamer University" Spotlight With New Ambitions for 2026
- New Epstein Book Details Explosive New Factoids about Epstein-Trump
- Stockdale Capital Announces Four New Major Hires
LOS ANGELES--(BUSINESS WIRE)--Respira Technologies, Inc.—a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases—has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira's founder, Mario Danek, will transition to the role of Chief Technology Officer.
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
- California: Governor Newsom announces appointments 3.23.2026
- Breaking the Civilian Barrier: ResuModAI Helps Veterans Translate Military Service into Job Offers in 60 Seconds
- Global Leaders Meet in Baku: The World Is Running Out of Time
- Long Beach Parks, Recreation and Marine to Offer Youth Summer Day Camps
- USFITC Extends International Defense Supply Capabilities with Sealing Component Delivery
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Filed Under: Business
0 Comments
Latest on The Californer
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- A-One Janitorial Wins $152M AI Campus Contract — Meta, Microsoft, Google, and AWS
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- Countrywide Rental Strengthens Waste Management Services Across Bankston Campuses
- Burbank Startup XBYZ LLC Launches Full-Service Business Platform for California Entrepreneurs
- Official Statement On The Passing Of KiKi Shepard From The Shepard Family
- QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
- Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
- Fashion Sourcing — Simplifying Global Sourcing with Transparency in Manufacturing
- Fashion Sourcing — The B2B Online Marketplace for Custom Clothing Manufacturing
- Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
- On The Mark Digital Launches AISEO Services for Local Business AI Visibility
- High5VR Announces World's First Fully Immersive First-Person VR Movie
- HomeIQ Academy Launches Free Buyer Education Platform to Help Real Estate Agents Close More Deals
- The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet